Department of Medicine, Lubaga Hospital, Kampala, Uganda
Department of Internal Medicine, Kilimanjaro Christian Medical Centre, Moshi, Kilimanjaro, Tanzania.
BMJ Open. 2022 Nov 8;12(11):e060786. doi: 10.1136/bmjopen-2022-060786.
Contemporary data on the attainment of optimal diabetes treatment goals and the burden of diabetes complications in adult populations with type 2 diabetes in Africa are lacking. We aimed to document the current status of attainment of three key indicators of optimal diabetes care and the prevalence of five diabetes complications in adult African populations with type 2 diabetes.
We systematically searched Embase, PubMed and the Cochrane library for published studies from January 2000 to December 2020. Included studies reported any information on the proportion of attainment of optimal glycated haemoglobin (HbA1c), blood pressure (BP) and low-density lipoprotein cholesterol (LDLC) goals and/or prevalence of five diabetes complications (diabetic peripheral neuropathy, retinopathy, nephropathy, foot ulcers and peripheral arterial disease). Random effect model meta-analysis was performed to determine the pooled proportion of attainment of the three treatment goals and the prevalence of five diabetes complications.
In total, 109 studies with a total of 63 890 participants (53.3% being females) were included in the meta-analysis. Most of the studies were conducted in Eastern African countries (n=44, 40.4%). The pooled proportion of attainment of an optimal HbA1c, BP and LDLC goal was 27% (95% CI 24 to 30, I=94.7%), 38% (95% CI 30 to 46, I=98.7%) and 42% (95% CI 32 to 52, I=97.4%), respectively. The pooled prevalence of diabetic peripheral neuropathy, retinopathy, diabetic nephropathy, peripheral arterial disease and foot ulcers was 38% (95% CI 31 to 45, I=98.2%), 32% (95% CI 28 to 36, I=98%), 31% (95% CI 22 to 41, I=99.3%), 19% (95% CI 12 to 25, I=98.1%) and 11% (95% CI 9 to 14, I=97.4%), respectively.
Attainment of optimal diabetes treatment goals, especially HbA1c, in adult patients with type 2 diabetes in Africa remains a challenge. Diabetes complications, especially diabetic peripheral neuropathy and retinopathy, are highly prevalent in adult populations with type 2 diabetes in Africa.
目前缺乏关于非洲 2 型糖尿病成年人群实现最佳糖尿病治疗目标和糖尿病并发症负担的当代数据。本研究旨在记录目前实现三项关键糖尿病护理指标的现状,以及非洲成年 2 型糖尿病患者五种糖尿病并发症的流行情况。
我们系统地检索了 Embase、PubMed 和 Cochrane 图书馆,以获取 2000 年 1 月至 2020 年 12 月发表的研究。纳入的研究报告了关于实现最佳糖化血红蛋白(HbA1c)、血压(BP)和低密度脂蛋白胆固醇(LDLC)目标的比例以及五种糖尿病并发症(糖尿病周围神经病变、视网膜病变、肾病、足部溃疡和外周动脉疾病)的任何信息。采用随机效应模型荟萃分析来确定三项治疗目标的总体实现比例和五种糖尿病并发症的流行情况。
共有 109 项研究,总计 63890 名参与者(53.3%为女性)纳入荟萃分析。大多数研究来自东非国家(n=44,40.4%)。实现 HbA1c、BP 和 LDLC 目标的最佳比例分别为 27%(95%CI 24 至 30,I=94.7%)、38%(95%CI 30 至 46,I=98.7%)和 42%(95%CI 32 至 52,I=97.4%)。糖尿病周围神经病变、视网膜病变、糖尿病肾病、外周动脉疾病和足部溃疡的总体患病率分别为 38%(95%CI 31 至 45,I=98.2%)、32%(95%CI 28 至 36,I=98%)、31%(95%CI 22 至 41,I=99.3%)、19%(95%CI 12 至 25,I=98.1%)和 11%(95%CI 9 至 14,I=97.4%)。
在非洲,2 型糖尿病成年患者实现最佳糖尿病治疗目标,尤其是 HbA1c,仍然是一个挑战。糖尿病并发症,尤其是糖尿病周围神经病变和视网膜病变,在非洲成年 2 型糖尿病患者中非常普遍。